
Tesamorelin + Ipamorelin + CJC-1295 Trio
GHRH + GHRP + GHRH-DAC stack.
- Sizes available
- —
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Triple GH-axis stack: tesamorelin, ipamorelin, and CJC-1295 (GHRH + GHRP + DAC).
Mechanism · Triple GH-axis blend. Full GHRH and GHRP synergy.
Best for. Not for.
Best for
- Multi-axis GH stimulation (visceral fat and recovery).
- Users who want tesamorelin (FDA-approved Egrifta) efficacy.
- Single-injection convenience with GHRH and GHRP synergy.
Not for
- Tesamorelin warnings: children, pregnancy, active malignancy.
- GH-class warnings: diabetic retinopathy, uncontrolled diabetes.
- Acromegaly.
Mechanism, dose, ramp, risk.
- Mechanism
- Three-compound stack. Synergistic GH pulses.Source · PEPVERA editorial
- Target dose
- Per protocol.Source · PEPVERA editorial
- Ramp
- 12-Week cycle.Source · PEPVERA editorial
- Risks
- Per components.Source · PEPVERA editorial
Compared to its siblings.
Tesamorelin + Ipamorelin + CJC-1295 Trio
Triple GH-axis stack: tesamorelin, ipamorelin, and CJC-1295 (GHRH + GHRP + DAC).
Pros
- · Tesamorelin (Egrifta) FDA-approved efficacy on visceral fat absent in cheaper two-way GHRH + GHRP blends.
Cons
- · Higher cost than a two-way ipamorelin + CJC-1295 blend.
Ipamorelin + CJC Blend
Two-way GHRH + GHRP without tesamorelin. Cheaper.
Pros
- · Cost.
Cons
- · Weaker visceral-fat efficacy.
See Ipamorelin + CJC Blend →
Tesamorelin + Ipamorelin + CJC-1295
Equivalent stack listed under a separate SKU.
Pros
- · Equivalent.
Cons
- ·
See Tesamorelin + Ipamorelin + CJC-1295 →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 0 suppliers
No verified suppliers yet for this compound.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Per components. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
12-Week cycle.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1–2
Per protocol.
Initiation
Week 3–4
Per protocol.
Signal emerges
Week 5–8
Per protocol.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.
apex · XIII
Tesamorelin + Ipamorelin + CJC-1295 Trio · 10mg